Search

for
Search:

GlossaryLiraglutide (Victoza)

medication mimicking GLP-1 hormone to regulate blood sugar

Liraglutide is a medication that mimics a hormone called GLP-1 (glucagon-like peptide-1) to help regulate blood sugar levels and appetite. It is commonly used to treat type 2 diabetes under the brand name Victoza and for weight management under the brand name Saxenda.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 13 results

research A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa: A Case Report

9 citations, July 2017 in “Case Reports in Dermatology”

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

research Combination of Metformin With Liraglutide in Treating HAIR-AN Syndrome in Children: A Case Report and Literature Review

December 2023 in “PubMed”

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

research The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome

July 2023 in “Journal of Clinical Medicine”

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

research Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing

68 citations, January 2022 in “International Journal of Molecular Sciences”

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

research GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

59 citations, August 2021 in “Frontiers in Endocrinology”

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

View more "victoza" in research →

Community Join

0 / 0 results

— no results